About Lassen Therapeutics
Lassen Therapeutics is a company based in San Diego (United States) founded in 2019.. Lassen Therapeutics has raised $116 million across 2 funding rounds from investors including Frazier Healthcare Partners, Longitude Capital and BVF Partners. The company has 6 employees as of December 31, 2019. Lassen Therapeutics offers products and services including LASN01 and LASN500. Lassen Therapeutics operates in a competitive market with competitors including Zymeworks, Xilio Therapeutics, Harbour BioMed, Ambrx and Leap Therapeutics, among others.
- Headquarter San Diego, United States
- Employees 6 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lassen Therapeutics 1, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$116 M (USD)
in 2 rounds
-
Latest Funding Round
$85 M (USD), Series B
Dec 19, 2023
-
Investors
Frazier Healthcare Partners
& 5 more
-
Employee Count
6
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lassen Therapeutics
Lassen Therapeutics offers a comprehensive portfolio of products and services, including LASN01 and LASN500. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats Thyroid Eye Disease by blocking IL-11 pathway
Advances investigational drugs for fibrosis-related conditions
Unlock access to complete
Unlock access to complete
Funding Insights of Lassen Therapeutics
Lassen Therapeutics has successfully raised a total of $116M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $85 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $85.0M
-
First Round
First Round
(17 Jun 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Series B - Lassen Therapeutics | Valuation | Frazier Healthcare Partners , Longitude Capital | |
| Jun, 2020 | Amount | Series A - Lassen Therapeutics | Valuation | Frazier Healthcare Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lassen Therapeutics
Lassen Therapeutics has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners, Longitude Capital and BVF Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lassen Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lassen Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lassen Therapeutics Comparisons
Competitors of Lassen Therapeutics
Lassen Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zymeworks, Xilio Therapeutics, Harbour BioMed, Ambrx and Leap Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Bi-specific antibodies and antibody-drug conjugates are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Tumor-selective immunotherapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antibody therapeutics are developed for immunology and oncology diseases.
|
|
| domain | founded_year | HQ Location |
Antibody-drug conjugates are developed for cancers and metabolic disorders.
|
|
| domain | founded_year | HQ Location |
Novel immuno-oncology therapeutics are acquired and developed for clinical advancement.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lassen Therapeutics
Frequently Asked Questions about Lassen Therapeutics
When was Lassen Therapeutics founded?
Lassen Therapeutics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Lassen Therapeutics located?
Lassen Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Lassen Therapeutics a funded company?
Lassen Therapeutics is a funded company, having raised a total of $116M across 2 funding rounds to date. The company's 1st funding round was a Series A of $31M, raised on Jun 17, 2020.
How many employees does Lassen Therapeutics have?
As of Dec 31, 2019, the latest employee count at Lassen Therapeutics is 6.
What does Lassen Therapeutics do?
Lassen Therapeutics was founded in 2019 in San Diego, United States, within the biotechnology sector. Biotherapeutics aimed at cancer treatment are developed, with a focus on the tumor microenvironment and fibrosis mediation. A lead monoclonal antibody targeting interleukin-11 has been advanced. The pipeline includes LASN01, directed at IL-11-R in the preclinical stage, and LASN02, for an undisclosed target in discovery.
Who are the top competitors of Lassen Therapeutics?
Lassen Therapeutics's top competitors include Xilio Therapeutics, Ambrx and Harbour BioMed.
What products or services does Lassen Therapeutics offer?
Lassen Therapeutics offers LASN01 and LASN500.
Who are Lassen Therapeutics's investors?
Lassen Therapeutics has 6 investors. Key investors include Frazier Healthcare Partners, Longitude Capital, BVF Partners, Catalio Capital Management, and Alta Partners.